Polio News and Research

RSS
Poliomyelitis (polio) is a highly infectious disease caused by a virus that invades the nervous system and can cause severe paralysis. The virus enters the body through the mouth and multiplies in the intestine. Initial symptoms are fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs. One in 200 infections leads to irreversible paralysis (usually in the legs). Among those paralyzed, 5-10% die when their breathing muscles become immobilized. Polio mainly affects children under five years of age. Naturally occurring polio was eliminated in the U.S. in 1979 and in the Western Hemisphere by 1991; however, worldwide efforts are continuing towards eradication of this contagious and devastating disease.
CDC Health Alert Network provides recommendations to manage the recent increase in severe respiratory illness among children

CDC Health Alert Network provides recommendations to manage the recent increase in severe respiratory illness among children

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

The impact of the infant gut microbiome on vaccine efficacy

The impact of the infant gut microbiome on vaccine efficacy

Pakistan faces widespread outbreaks of infectious diseases amid unprecedented floods

Pakistan faces widespread outbreaks of infectious diseases amid unprecedented floods

‘He stood his ground’: California state Senator will leave office as champion of tough vaccine laws

‘He stood his ground’: California state Senator will leave office as champion of tough vaccine laws

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

KHN’s ‘What the Health?’: The future of public health, 2022 edition

KHN’s ‘What the Health?’: The future of public health, 2022 edition

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Exploring a paralytic poliomyelitis case in an unvaccinated person

Exploring a paralytic poliomyelitis case in an unvaccinated person

Poliovirus detected in New York City wastewater

Poliovirus detected in New York City wastewater

Big pharma went all in to kill drug pricing negotiations

Big pharma went all in to kill drug pricing negotiations

Covid sewage surveillance labs join the hunt for monkeypox

Covid sewage surveillance labs join the hunt for monkeypox

What the polio case in New York tells us about the end of polio

What the polio case in New York tells us about the end of polio

India, Pakistan tackle backslide in child immunizations

India, Pakistan tackle backslide in child immunizations

Conservative blocs unleash litigation to curb public health powers

Conservative blocs unleash litigation to curb public health powers

Using microparticles to create 'self-boosting' vaccines

Using microparticles to create 'self-boosting' vaccines

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

Study underscores the strong protective effect of flu vaccine against Alzheimer's disease

Study underscores the strong protective effect of flu vaccine against Alzheimer's disease

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

The effect of immunization with bivalent oral poliovirus vaccine on the incidence of COVID-19

Will the US overcome its covid complacency even as the threat returns?

Will the US overcome its covid complacency even as the threat returns?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.